The FDA has approved ritlecitinib (LITFULO™) for patients aged 12 years and above with severe alopecia areata.
A recent study evaluated how REVIVV®could help patients with androgenetic alopecia improve their quality of life and emotional wellbeing.
Dr. Brett A. King and Dr. Brittany G. Craiglow share valuable insight into the autoimmune disease, alopecia areata, in light of recent medical breakthroughs.
There is a need to raise awareness about topical steroid withdrawal (TSW), a serious potential side effect of topical steroid use. TSW is not always recognized by patients or practitioners as much is still unknown about this consequence of using topical steroids, particularly in the long term. What are skin conditions? Common skin conditions […]
Alopecia is the abnormal loss of hair on the scalp, face, or body thought to be the result of both genetic and environmental factors. Although people from any race can develop the condition, there is a specific type of hair loss that is especially common among Black women. Even celebrities can develop this condition; Jada […]
Most dermatologists have not historically considered their patients’ sexual orientation and gender identity as relevant to their practice, but new data contributes to awareness in skin health disparities in patients from sexual and gender diverse (SGD) communities. Dermatologists who strive to understand their patients can better see them as a whole person, engage in a […]